Synthesis of fluorescent analogues of the anticancer natural products 4-hydroxyphenylmethylene hydantoin and δ-tocotrienol

Natural Product Communications

Volumn 5, Issue 10, 2010, Pages 1623-1626

  Mudit, Mudit ^a   Behery, Fathy A ^a   Wali, Vikram B ^a   Sylvester, Paul W ^a   El Sayed, Khalid A ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Anticancer; Fluorescent labeling; Palm oil; Phenylmethylene hydantoin; Red Sea sponge; Tocotrienol

Indexed keywords

4 HYDROXYPHENYLMETHYLENE HYDANTOIN; ANTINEOPLASTIC AGENT; DELTA TOCOTRIENOL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ISOLATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

HEMIMYCALE ARABICA;

EID: 77957911900     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1000501022     Document Type: Article

References (12)

1. (a) American Cancer Society Website. http://www.cancer.org/docroot/stt/ stt-0.asp?from=fast, Statistics for 2009, accessed (May 6, 2010).
2. (b) Beckmann N. (2006) In vivo MR Techniques in Drug Discovery and Development. Informa Healthcare, Taylor and Francis Group, New York. 1-557;
3. (c) Valeur B. (2002) Molecular Fluorescence: Principles and Applications. Wiley VCH, Weinheim, Germany. 1-400;
4. (d) Yu TZ, Zhao YL, Ding XS, Fan DW, Qian L, Dong WK. (2007) Synthesis, crystal structure and photoluminescent behaviors of 3-(1H-benzotriazol-1-yl)-4- methyl-benzo[7,8]coumarin. Journal of Photochemistry and Photobiology, A: Chemistry, 188, 245-251;
5. (e) Mudit M, Khanfar M, Muralidharan A, Thomas S, Shah GV, van Soest RWM, El Sayed KA. (2009) Discovery, design, and synthesis of anti-metastatic lead phenylmethylene hydantoins inspired by marine natural products. Bioorganic & Medicinal Chemistry, 17, 1731-1738;
6. (f) Shah GV, Muralidharan A, Thomas S, Gokulgandhi M, Mudit M, Khanfar M, El Sayed KA. (2009) Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis. Molecular Cancer Therapeutics, 8, 509-520.
7. (a) Nesaretnam K, Ambra R, Selvaduray KR. (2004) Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Annals of the New York Academy of Sciences, 1031, 143-157; (Pubitemid 40361750)
8. (b) Sylvester PW, Theriault A. (2003) Role of tocotrienols in the prevention of cardiovascular disease and breast cancer. Current Topics in Nutraceutical Research, 1, 121-136.
9. (a) Steglich W, Hofle G. (1969) N,N-Dimethyl-4-pyridinamine, a very effective acylation catalyst. Angewandte Chemie International Edition, 8, 981;
10. (b) Ziegler FE, Berger GD. (1979) A mild method for the esterification of fatty acids. Synthetic Communications, 9, 539-543;
11. (c) Eitenmiller R, Lee J. (2004) Vitamin E: Food Chemistry, Composition, and Analysis. Marcel Dekker Inc., New York. 1-380;
12. (d) McIntyre BS, Briski KP, Gabor A, Sylvester PW. (2000) Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Proceedings of the Society for Experimental Biology and Medicine, 224, 292-301. (Pubitemid 30643508)